Finance

Beta
Lists
DNTH:NASDAQ
Dianthus Therapeutics Inc
$80.51
-4.30%
(-3.62) 1D
$80.51
0.00% (0.00)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DNTH...
Open
$84.03
High
$85.82
Low
$79.64
Mkt. cap
4.40B
Avg. vol.
551.31K
Volume
835.88K
52-wk high
$96.50
52-wk low
$16.64
EPS
-$4.14
Beta
1.18
Shares outstanding
54.67M
No. of employees
92
Open
$84.03
High
$85.82
Low
$79.64
Mkt. cap
4.40B
Avg. vol.
551.31K
Volume
835.88K
52-wk high
$96.50
52-wk low
$16.64
EPS
-$4.14
Beta
1.18
Shares outstanding
54.67M
No. of employees
92
Analyst outlook
Analyst Ratings
Based on 15 analysts giving stock ratings to DNTH in the past 3 months
Strong Buy
Buy
15
Hold
0
Sell
0
12 month forecast
Based on 15 Wall Street analysts offering 12 month price targets for DNTH in the last 3 months.
Highest
Current $80.51
$200.00 (+148.42%)
Average
$122.57 (+52.24%)
Lowest
$90.00 (+11.79%)
News stories
From sources across the web
About Dianthus Therapeutics Inc
CEO-
Employees92
Founded2019
Headquarters-
SectorBiotechnology
Websitedianthustx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
193.00K
396.00K
284.00K
463.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
26.25M
32.49M
59.92M
34.53M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.87M
8.20M
9.91M
12.47M
Operating expense
35.12M
40.68M
69.82M
47.00M
Total operating expenses
35.12M
40.68M
69.82M
47.00M
Operating income
-34.93M
-40.29M
-69.54M
-46.53M
Other non operating income
-107.00K
-360.00K
-409.00K
-249.00K
EBT including unusual items
-31.63M
-36.76M
-64.43M
-40.83M
EBT excluding unusual items
-32.76M
-39.30M
-65.54M
-41.75M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-31.63M
-36.76M
-64.43M
-40.83M
Net profit margin
-16,388.08%
-9,284.09%
-22,687.32%
-8,819.44%
Earnings per share
-0.88
-0.97
-1.43
-0.85
Interest and investment income
2.30M
1.35M
4.41M
5.05M
Interest expense
-
-
-
-
Net interest expenses
2.30M
1.35M
4.41M
5.05M
Depreciation and amortization charges
-
-
-
-
EBITDA
-34.90M
-40.26M
-69.51M
-46.50M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer